H1 FY26 Appendix 4D and Half Year Report
Filed with ASX · · 23 pages · English
1) Not Meaningful: As the Group was in a loss position in the prior year, the % change movement relating to the improved performance (i.e. prior year loss moving to current year profit) displays as a negative % change for these results. Details relating to dividends No dividends were paid or proposed for the current or previous corresponding half-year period. Explanation of results First half reve
In the deck
Story so far
Earlier from Alcidion
- Dual AU and UK Medical Device Registration for AI Capability
- Q2 FY26 Quarterly Activities Report and Appendix 4C
- Alcidion Selected as Preferred EPR Supplier
- Alcidion expands contract with Leidos Australia
- Q1 FY26 Quarterly Activities Report and Appendix 4C
Later from Alcidion
- H1 FY26 Results Presentation
- H1 FY26 Results Release
- Q3 FY26 Quarterly Activities Report and Appendix 4C
- Acquisition of the Kyra flow products from Telstra Health
- ALC signs 7-year contract with UHSussex for EPR platform
Follow Alcidion into a list and get an email when it puts out news.
Follow Alcidion